Quince Therapeutics Inc (NASDAQ: QNCX) on Monday, plunged -10.66% from the previous trading day, before settling in for the closing price of $4.22. Within the past 52 weeks, QNCX’s price has moved between $0.72 and $4.55.
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.53%. The company achieved an average annual earnings per share of 16.54%. With a float of $48.30 million, this company’s outstanding shares have now reached $54.49 million.
Quince Therapeutics Inc (QNCX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Quince Therapeutics Inc is 13.25%, while institutional ownership is 20.78%.
Quince Therapeutics Inc (QNCX) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.28 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.1) by -0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.83% during the next five years compared to 7.53% growth over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
Quince Therapeutics Inc (QNCX) is currently performing well based on its current performance indicators. A quick ratio of 1.12 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Quince Therapeutics Inc (QNCX)
Looking closely at Quince Therapeutics Inc (NASDAQ: QNCX), its last 5-days average volume was 0.92 million, which is a jump from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 70.31%.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 74.92%, which indicates a significant increase from 61.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.34, while its 200-day Moving Average is $1.65. However, in the short run, Quince Therapeutics Inc’s stock first resistance to watch stands at $4.10. Second resistance stands at $4.44. The third major resistance level sits at $4.62. If the price goes on to break the first support level at $3.58, it is likely to go to the next support level at $3.40. Now, if the price goes above the second support level, the third support stands at $3.06.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
Market capitalization of the company is 209.92 million based on 55,681K outstanding shares. Right now, sales total 0 K and income totals -56,830 K. The company made 0 K in profit during its latest quarter, and -13,440 K in sales during its previous quarter.
